A multimodal machine learning model for predicting dementia conversion in Alzheimer's disease

Min-Woo Lee,Hye Weon Kim,Yeong Sim Choe,Hyeon Sik Yang,Jiyeon Lee,Hyunji Lee,Jung Hyeon Yong,Donghyeon Kim,Minho Lee,Dong Woo Kang,So Yeon Jeon,Sang Joon Son,Young-Min Lee,Hyug-Gi Kim,Regina E. Y. Kim,Hyun Kook Lim
DOI: https://doi.org/10.1038/s41598-024-60134-2
IF: 4.6
2024-05-30
Scientific Reports
Abstract:Alzheimer's disease (AD) accounts for 60–70% of the population with dementia. Mild cognitive impairment (MCI) is a diagnostic entity defined as an intermediate stage between subjective cognitive decline and dementia, and about 10–15% of people annually convert to AD. We aimed to investigate the most robust model and modality combination by combining multi-modality image features based on demographic characteristics in six machine learning models. A total of 196 subjects were enrolled from four hospitals and the Alzheimer's Disease Neuroimaging Initiative dataset. During the four-year follow-up period, 47 (24%) patients progressed from MCI to AD. Volumes of the regions of interest, white matter hyperintensity, and regional Standardized Uptake Value Ratio (SUVR) were analyzed using T1, T2-weighted-Fluid-Attenuated Inversion Recovery (T2-FLAIR) MRIs, and amyloid PET (αPET), along with automatically provided hippocampal occupancy scores (HOC) and Fazekas scales. As a result of testing the robustness of the model, the GBM model was the most stable, and in modality combination, model performance was further improved in the absence of T2-FLAIR image features. Our study predicts the probability of AD conversion in MCI patients, which is expected to be useful information for clinician's early diagnosis and treatment plan design.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper attempts to address the problem of predicting whether patients with mild cognitive impairment (MCI) will develop Alzheimer's disease (AD). Specifically, the researchers explore the most robust machine learning models and their modality combinations by integrating various imaging features and demographic characteristics to improve prediction accuracy. ### Background and Motivation - **Alzheimer's Disease (AD)** is the most common neurodegenerative disease, accounting for 60-70% of all dementia cases. - **Mild Cognitive Impairment (MCI)** is a diagnostic stage between subjective cognitive decline and dementia, with approximately 10-15% of MCI patients progressing to AD each year. - **Early diagnosis and intervention** are crucial for delaying disease progression and improving patients' quality of life. ### Research Objectives - **Primary Objective**: Develop a multimodal machine learning model capable of predicting whether MCI patients will progress to AD. - **Secondary Objective**: Evaluate the impact of different modality combinations on model performance and select the most robust model and modality combination. ### Methods - **Data Source**: Collected imaging and clinical data from 196 subjects from four hospitals and the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. - **Imaging Features**: Included regional volumes from T1-weighted MRI, T2-FLAIR MRI, and amyloid PET (αPET) images, white matter hyperintensities (WMH), standardized uptake value ratio (SUVR), etc. - **Demographic Features**: Included age, gender, Mini-Mental State Examination (MMSE) score, APOE ε4 gene carrier status, etc. - **Model Selection**: Tested six commonly used machine learning models, including Decision Tree (DT), Random Forest (RF), Support Vector Machine (SVM), Linear Regression Classifier (LR), Gradient Boosting Model (GBM), and Extreme Gradient Boosting (XGB). - **Modality Combinations**: Evaluated 11 different modality combinations, including using only demographic features, only imaging features, and various combinations. ### Results - **Best Model**: The GBM model performed the most robustly across all modality combinations, with the highest average AUC and the smallest standard deviation. - **Best Modality Combination**: In the GBM model, the combination of demographic features and T1-weighted MRI, αPET image features (demo+AN) performed the best, achieving an AUC of 0.881. - **Performance Evaluation**: The final model achieved a balanced accuracy (BA) of 0.744, sensitivity (SE) of 0.778, specificity (SP) of 0.710, and AUC of 0.875 on the test set. ### Conclusion This study successfully developed a multimodal machine learning model capable of effectively predicting whether MCI patients will progress to AD. The combination of demographic features and T1-weighted MRI, αPET image features performed the best. This model has the potential to provide useful information for clinicians in early diagnosis and treatment planning.